[The incidence of anti-HIV antibodies in hospitalized patients in a tuberculosis clinic] NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The incidence of anti-HIV antibodies in hospitalized patients in a tuberculosis clinic]

Rev Roum Virol. 1991 Jan-Jun;42(1-2):41-6. Unique Identifier : AIDSLINE MED/92162627
Ditu S; Banica M; Avram A; Cernescu C; Institut de Virologie Stefan S. Nicolau, Bucarest, Roumanie.

Abstract: HIV antibody prevalence was studied in 1274 patients, including 150 children, hospitalized in phthisiology services. The sixteen EIA positive samples were confirmed by the Western blot test (1.25%). The other seventeen EIA positive samples gave undetermined results in W.B. In children, antibody incidence was 7.33% versus 0.45% only in adults: this ratio seems to be characteristic for AIDS endemia in Romania, where parenteral transmission is the quasi unique way of HIV infection dissemination in children. The presence of nonspecific multiple bands in the gp 41 region was noted on seven of the seventeen undetermined samples, which is to confirm the reports about the presence of W.B. detectable anti-HIV antibodies cross-reacting with anti-mycobacterial antibodies.
Keywords: Age Factors Blotting, Western Chronic Disease Comparative Study English Abstract *Hospitals, Special Human HIV Antibodies/BLOOD *HIV Seroprevalence HIV-1/IMMUNOLOGY Incidence Respiratory Tract Diseases/EPIDEMIOLOGY/IMMUNOLOGY Romania/EPIDEMIOLOGY Seroepidemiologic Methods Tuberculosis, Pulmonary/EPIDEMIOLOGY/*IMMUNOLOGY JOURNAL ARTICLEKWDagefactorsblotting,westernchronicdiseasecomparativestudyenglishabstractKWDhospitals,specialhumanhivantibodies/bloodKWDhivseroprevalencehiv-1/immunologyincidencerespiratorytractdiseases/epidemiology/immunologyromania/epidemiologyseroepidemiologicmethodstuberculosis,pulmonary/epidemiology/KWDimmunologyjournalarticle
920630
M9260981

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .